DNMT3A and lung carcinoma: Thus, despite increased DNMT3A transcripts in lung cancers, DNMT3A at the level of proteins is actually substantially reduced in lung tumors, most likely as a consequence of targeted degradation of DNMT3A by overexpressed UHRF1/2.